📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Avigen

1.1 - Company Overview

Avigen Logo

Avigen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical R&D focused on treatments for neurological and other disorders. Develops the AV411 portfolio, including a phase II-stage lead drug compound and proprietary analogs, representing novel, non-opioid drugs for the treatment of pain.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Avigen

Hyperion Therapeutics Logo

Hyperion Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies focused on treating urea cycle disorders and other rare diseases for orphan or underserved patient populations; based in South San Francisco, CA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hyperion Therapeutics company profile →
Quellis Bio Logo

Quellis Bio

HQ: United States Website
  • Description: Provider of next-generation antibody therapies aimed at improving outcomes for patients with serious rare diseases, focusing on discovering best-in-class new molecules to address underserved treatment needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quellis Bio company profile →
Oxyrane Logo

Oxyrane

HQ: United Kingdom Website
  • Description: Provider of novel and biosuperior enzyme replacement therapies for lysosomal storage diseases. Pipeline includes OxyGCase for neuronopathic Gaucher disease and OXY2810 for Pompe disease. Offers the OxyCAT glycoengineered yeast-based platform to produce ERTs with enhanced cellular uptake and pharmacodynamics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxyrane company profile →
Imara Logo

Imara

HQ: United States Website
  • Description: Provider of novel therapeutics for people living with sickle cell disease and hemoglobinopathies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Imara company profile →
Primrose Therapeutics Logo

Primrose Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on creating treatments for polycystic kidney disease (PKD), a life-threatening genetic disorder affecting 600,000 Americans and 12.5 million people worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Primrose Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Avigen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Avigen

2.2 - Growth funds investing in similar companies to Avigen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Avigen

4.2 - Public trading comparable groups for Avigen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Avigen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Avigen

What does Avigen do?

Avigen is a provider of biopharmaceutical R&D focused on treatments for neurological and other disorders. Develops the AV411 portfolio, including a phase II-stage lead drug compound and proprietary analogs, representing novel, non-opioid drugs for the treatment of pain.

Who are Avigen's competitors?

Avigen's competitors and similar companies include Hyperion Therapeutics, Quellis Bio, Oxyrane, Imara, and Primrose Therapeutics.

Where is Avigen headquartered?

Avigen is headquartered in United States.

How many employees does Avigen have?

Avigen has 1,000 employees 🔒.

When was Avigen founded?

Avigen was founded in 2010 🔒.

What sector and industry vertical is Avigen in?

Avigen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Avigen

Who are the top strategic acquirers in Avigen's sector and industry

Top strategic M&A buyers and acquirers in Avigen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Avigen?

Top strategic M&A buyers groups and sectors for Avigen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Avigen's sector and industry vertical

Which are the top PE firms investing in Avigen's sector and industry vertical?

Top PE firms investing in Avigen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Avigen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Avigen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Avigen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Avigen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Avigen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Avigen?

The key public trading comparables and valuation benchmarks for Avigen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Avigen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Avigen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Avigen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Avigen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Avigen's' sector and industry vertical?

Access recent funding rounds and capital raises in Avigen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Avigen

Launch login modal Launch register modal